Clinical Study
Consistency of Mycobacterium tuberculosis-Specific Interferon-Gamma Responses in HIV-1-Infected Women during Pregnancy and Postpartum
Table 1
Interferon-γ release assay results during postpartum in HIV-1-infected women who were interferon-γ release assay positive during pregnancy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note: IGRA interferon-gamma release assay. This table is sorted by consistency of positive postpartum IGRAs. The first nine rows display IGRA responses in women who had all positive postpartum IGRAs. The next 6 rows display IGRA responses in women who fluctuated between positive and negative IGRAs postpartum. The last 3 rows display IGRA responses in women who had all negative postpartum IGRA. *Maximum of ESAT-6/CPF-10 minus negative control. †Blank cells represent visits with indeterminate responses. ‡Consistent positive IGRAs is defined as all postpartum visits with positive IGRAs, excluding visits with indeterminate responses. |